Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboons

about

Utility of Nonhuman Primates in Substance Use Disorders Research.Key interindividual determinants in MDMA pharmacodynamics.

P2860

Q38680773-6CE5DEA1-1ACF-4A2B-A12D-05BC3F09136F Q47206849-049D6D3B-1FE1-4B45-A5C6-7A4F0EF2D17B

P2860

Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboons

Item

http://www.wikidata.org/entity/Q36852604

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Behavioral effects and pharmac ...... tric administration to baboons

@en

type

Item

label

Behavioral effects and pharmac ...... tric administration to baboons

@en

prefLabel

Behavioral effects and pharmac ...... tric administration to baboons

@en

P1476

Behavioral effects and pharmac ...... tric administration to baboons

@en

P2093

Amy K Goodwin

http://www.w3.org/2001/XMLSchema#string

Courtney D Shell

http://www.w3.org/2001/XMLSchema#string

George A Ricaurte

http://www.w3.org/2001/XMLSchema#string

Melanie Mueller

http://www.w3.org/2001/XMLSchema#string

Nancy A Ator

http://www.w3.org/2001/XMLSchema#string

P2860

Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study.

Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes.

Neurotoxicity of ecstasy (MDMA): an overview.

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.

Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.

The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA).

Understanding subtypes of inner-city drug users with a latent class approach

Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans.

P304

342-353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.113.203729

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

345

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236068395

http://www.w3.org/2001/XMLSchema#string

P698

23516331

http://www.w3.org/2001/XMLSchema#string

P932

3657112

http://www.w3.org/2001/XMLSchema#string

Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboons

about

P2860

P2860

Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboons

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932